FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns a method for predicting the outcome from the unconscious state of a traumatic or metabolic genesis in a subject comprising obtaining a biological sample from said subject; at least once analysis of said biological sample to determine the level of antibodies to one or more fragments of kainate GluR6 and/or GluR7 receptors; comparison of this level with the level of the corresponding antibodies in samples taken from healthy subjects; at a low level of antibodies in a sample of a subject in an unconscious state that does not exceed the control level fixed in the samples of healthy subjects, predicting a favorable exit from the unconscious state; at increased level of antibodies in a sample of a subject in an unconscious state that exceeds the control level recorded in healthy subjects, predicting an unfavorable outcome of the disease. Group of inventions also relates to a method for predicting the release from the unconscious state of a traumatic or metabolic genesis in a subject comprising obtaining at least two biological samples from said subject in the range from 1 hour to 90 days; analysis of these biological images to determine the level of antibodies to one or more fragments of the kainate receptors GluR6 and/or GluR7; comparing the levels of the respective antibodies determined in different samples of one subject, with each other and with the level of the corresponding antibodies in the samples taken from healthy subjects.
EFFECT: group of inventions ensures prediction of both restoration of the subject's consciousness with a favorable outcome, as well as the probability of transition to a chronic vegetative state or a lethal outcome.
10 cl, 3 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING FAVORABLE OUTCOME OF CHRONIC IMPAIRMENT OF CONSCIOUSNESS IN WOMEN | 2023 |
|
RU2806101C1 |
METHOD FOR PREDICTING RECOVERY OF CONSCIOUSNESS IN VEGETATIVE NON-TRAUMATIC GENESIS IN PATIENTS BASED ON BRAIN BACKGROUND BIOELECTRIC ACTIVITY AFTER ZOLPIDEM ADMINISTRATION | 2018 |
|
RU2697230C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF CEREBRAL WOUND DYSTROPHY | 2010 |
|
RU2426992C1 |
DIAGNOSTIC KIT OF REAGENTS FOR DETECTING CHRONIC PATHOLOGIES OF THE BRAIN OF ISCHEMIC GENESIS | 2017 |
|
RU2668534C1 |
BIOMARKERS OF ISCHEMIA AND THEIR APPLICATION FOR PREDICTION OF UNFAVOURABLE NEUROLOGIC CONSEQUENCES OF SURGICAL OPERATION | 2006 |
|
RU2435165C2 |
METHOD FOR PREDICTING THE PROBABILITY OF FATAL OUTCOME IN 14-DAY PERIOD OF ACUTE ISCHEMIC STROKE OF THE BRAIN | 2020 |
|
RU2748685C1 |
MODIFIED PEPTIDE AND USING IT FOR CNS CANCER SCREENING AND THERAPEUTIC EFFECTIVENESS TESTS | 2009 |
|
RU2491291C2 |
METHOD FOR PREDICTING TRAUMATIC BRAIN COMPRESSION OUTCOME | 2004 |
|
RU2276364C1 |
METHODS FOR IDENTIFYING AND PREDICTING RISK OF CARDIOVASCULAR EVENT OR DISEASE OR FATAL OUTCOME, METHODS FOR ASSESSING SEVERITY AND MONITORING OF CARDIOVASCULAR EVENT OR DISEASE, METHOD FOR MONITORING EFFECTIVENESS OF THERAPY | 2014 |
|
RU2721690C2 |
METHOD FOR PREDICTING RISK OF SUBJECTS CONTRACTING DIABETES MELLITUS AND/OR METABOLIC SYNDROME OR FOR DIAGNOSING METABOLIC SYNDROME IN SUBJECTS | 2013 |
|
RU2685713C2 |
Authors
Dates
2018-03-26—Published
2016-12-21—Filed